[HTML] spandidos-publications.com

[HTML][HTML] Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology letters, 2016 - spandidos-publications.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …
被引用次数：59 相关文章

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z LIU, YY ZHU, ZY LI, SIQ NING - ingentaconnect.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology letters, 2016 - pubmed.ncbi.nlm.nih.gov
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology Letters, 2016 - search.proquest.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology Letters, 2016 - go.gale.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …
[HTML] spandidos-publications.com

[HTML][HTML] Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology Letters, 2016 - spandidos-publications.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells.

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology Letters, 2016 - europepmc.org
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …
[HTML] nih.gov

[HTML][HTML] Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z Liu, YY Zhu, ZY Li, SQ Ning - Oncology Letters, 2016 - ncbi.nlm.nih.gov
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …
[PDF] semanticscholar.org

[PDF][PDF] Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells

Z LIU, YY ZHU, ZY LI, SIQ NING - pdfs.semanticscholar.org
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGA-phospholipid-PEG …

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells.

Z LIU, YY ZHU, ZY LI, SIQ NING - Oncology Letters, 2016 - search.ebscohost.com
The aim of the present study was to evaluate the efficacy of paclitaxel combined with
curcumin (CUR) against drug resistance in ovarian cancer cells. PLGAphospholipid-PEG …